Lifshitz Law Firm, P.C. Announces Investigation of CHNG, CPAH, HMSY, INFO, MGLN, NAV, OBLN, OXFD, and WTRE
NEW YORK, Feb. 7, 2021 /PRNewswire/ --
Change Healthcare Inc. (NASDAQ: CHNG)
Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of CHNG to Optum for $25.75 per share.
If you are a investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780.
CounterPath Corporation (NASDAQ-CM: CPAH)
Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of CPAH to Alianza, Inc. for $3.49 per share.
If you are a CPAH investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780.
HMS Holdings Corp. (NASDAQ: HMSY)
Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of HMSY to Gainwell Technologies for $37.00 per share.
If you are a HMSY investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780.
IHS Markit Ltd. (NYSE: INFO)
Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of INFO to SPGI for a fixed ratio of 0.2838 SPGI shares per INFO share.
If you are a investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780.
Magellan Health, Inc. (NASDAQ: MGLN)
Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of MGLN to Centene Corporation for $95.00 per share.
If you are a investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780.
Navistar International Corporation (NASDAQ: NAV)
Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of NAV to Traton for $44.50 per share.
If you are an investor, and would like additional information about our investigation, please complete the Information Request Form.
Obalon Therapeutics, Inc. (NASDAQ: OBLN)
Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the merger of OBLN with ReShape Lifesciences Inc.
If you are a investor, and would like additional information about our investigation, please complete the Information Request Form.
Oxford Immunotec Global PLC (NASDAQ: OXFD)
Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of OXFD to PerkinElmer, Inc. for $22.00 per share.
If you are a investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780.
Watford Holdings Ltd. (NASDAQ: WTRE)
Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of WTRE to Arch Capital Group for $31.10 per share.
If you are an investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780.
ATTORNEY ADVERTISING.© 2021 Lifshitz Law Firm, P.C. The law firm responsible for this advertisement is Lifshitz Law Firm, P.C., 1190 Broadway, Hewlett, NY 11557, Tel: (516)493-9780. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Contact:
Joshua M. Lifshitz, Esq.
Lifshitz Law Firm, P.C.
Phone: 516-493-9780
Facsimile: 516-280-7376
Email: [email protected]
SOURCE Lifshitz Law Firm
![](https://rt.prnewswire.com/rt.gif?NewsItemId=DC71985&Transmission_Id=202102070801PR_NEWS_USPR_____DC71985&DateId=20210207)
Share this article